Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8563)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2015 (publication date) through Nov 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2015; 21(1): 246-253 [PMID: 25574098 DOI: 10.3748/wjg.v21.i1.246] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/246.htm |
| Number | Citing Articles |
| 1 |
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World Journal of Gastroenterology 2019; 25(31): 4360-4382 doi: 10.3748/wjg.v25.i31.4360
|
| 2 |
Stéphanie Gonvers, Sebastiao Martins-Filho, André Hirayama, Julien Calderaro, Rebecca Phillips, Emilie Uldry, Nicolas Demartines, Emmanuel Melloul, Young Nyun Park, Valérie Paradis, Swan Thung, Venancio Alves, Christine Sempoux, Ismail Labgaa. Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors. Journal of Hepatocellular Carcinoma 2024; : 707 doi: 10.2147/JHC.S447848
|
| 3 |
Aline Mähringer‐Kunz, Verena Steinle, Christoph Düber, Arndt Weinmann, Sandra Koch, Irene Schmidtmann, Sebastian Schotten, Jan B. Hinrichs, Dirk Graafen, Daniel Pinto dos Santos, Peter R. Galle, Roman Kloeckner. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?. Liver International 2019; 39(2): 324 doi: 10.1111/liv.13988
|
| 4 |
Yangxun Pan, Jie Mei, Jinbin Chen, Deyao Zhang, Juncheng Wang, Xiaohui Wang, Minjiang Yi, Zhongguo Zhou, Yaojun Zhang, Minshan Chen, Rongping Guo, Li Xu. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma. Annals of Surgical Oncology 2022; 29(3): 2016 doi: 10.1245/s10434-021-10903-4
|
| 5 |
Jincheng Wang, Rui Wu, Jin-yu Sun, Feifei Lei, Huabing Tan, Xiaojie Lu. An overview: Management of patients with advanced hepatocellular carcinoma. BioScience Trends 2022; 16(6): 405 doi: 10.5582/bst.2022.01109
|
| 6 |
Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Kenji Wakayama. Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus. World Journal of Hepatology 2017; 9(36): 1296-1304 doi: 10.4254/wjh.v9.i36.1296
|
| 7 |
Yao Liu, Yuxin Li, Xiaojing Wang, Yunyi Huang, Qun Zhang, Ke Shi, Chongping Ran, Jie Hou, Xianbo Wang. Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3–4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment. The Journal of Alternative and Complementary Medicine 2020; 26(10): 956 doi: 10.1089/acm.2019.0334
|
| 8 |
Xiaojie Li, Zhimin Ye, Sheng Lin, Haowen Pang. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08469-1
|
| 9 |
Ryo Ashida, Yukiyasu Okamura, Keiichi Ohshima, Yuko Kakuda, Katsuhiko Uesaka, Teiichi Sugiura, Takaaki Ito, Yusuke Yamamoto, Takashi Sugino, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi. The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. Oncotarget 2018; 9(31): 22058 doi: 10.18632/oncotarget.25178
|
| 10 |
Jun Jia, Jing Sun, Xuezhang Duan, Wengang Li. Clinical Values and Markers of Radiation-Induced Liver Disease for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Stereotactic Body Radiotherapy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.760090
|
| 11 |
Zongrui Jin, Guolin Wu, Banghao Xu, Jilong Wang, Hai Zhu, Ya Guo, Minhao Peng, Tao Peng, Zhang Wen. Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.928452
|
| 12 |
Hikmet Akkiz, Brian I. Carr, Sedef Kuran, Ümit Karaoğullarından, Oguz Üsküdar, Salih Tokmak, Burcu Arslan, Figen Doran, Hüseyin Tugsan Balli, Abdulalh Ülkü, Tolga Atılgan Akçam, Halil İbrahim Bahçeci, Kamil Yalçın Polat, Necati Örmeci, Halis Şimşek, Abdullah Sonsuz, Ali Demir, Engin Altıntaş, Mehmet Demir, Kendal Yalçın, Nazım Ekinci, Ayşegül Harmancı Özakyol, Mehmet Yücesoy, Ahmet Uygun, Vito Guerra, Anıl Delik, Yaman Tokat, Sezai Yilmaz, Ahmet Bektaş, Murat Kılıç. Macroscopic Portal Vein Thrombosis in HCC Patients. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3120185
|
| 13 |
Naoki Kawagishi. HCC with portal vein tumor thrombosis: how to manage?. Hepatology International 2020; 14(5): 609 doi: 10.1007/s12072-020-10090-6
|
| 14 |
Akihiko Ichida, Takashi Kokudo, Shingo Shimada, Etsuro Hatano, Shoji Kubo, Yutaro Kato, Yoshiya Ishikawa, Akira Mori, Hideo Baba, Yutaka Matsuyama, Itaru Endo, Hiroki Yamaue, Masakazu Yamamoto, Norihiro Kokudo, Kiyoshi Hasegawa. Liver Resection for Hepatocellular Carcinoma With Tumor Thrombus in the Inferior Vena Cava or Right Atrium. Annals of Surgery 2023; 278(3): e549 doi: 10.1097/SLA.0000000000005789
|
| 15 |
Wangxia Tong, Jieyue Zhong, Qiuyan Yang, Han Lin, Bolun Chen, Tao Lu, Jibing Chen, Ning Luo. Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1414121
|
| 16 |
Jing-Wei Wei, Si-Rui Fu, Jie Zhang, Dong-Sheng Gu, Xiao-Qun Li, Xu-Dong Chen, Shuai-Tong Zhang, Xiao-Fei He, Jian-Feng Yan, Li-Gong Lu, Jie Tian. CT‐based radiomics to predict development of macrovascular invasion in hepatocellular carcinoma: A multicenter study. Hepatobiliary & Pancreatic Diseases International 2022; 21(4): 325 doi: 10.1016/j.hbpd.2021.09.011
|
| 17 |
Nicole Nevarez, Adam Yopp. Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Hepatocellular Carcinoma 2021; : 851 doi: 10.2147/JHC.S291530
|
| 18 |
Simone Famularo, Matteo Donadon, Federica Cipriani, Felice Giuliante, Silvia Ferri, Ciro Celsa, Alessandro Ferrero, Francesco Giuseppe Foschi, Gian Luca Baiocchi, Elisabetta Biasini, Claudia Campani, Raffaele Dalla Valle, Filippo Pelizzaro, Gianluca Svegliati Baroni, Giovanni Raimondo, Andrea Mega, Marco Chiarelli, Marcello Maestri, Antonio Gasbarrini, Elio Jovine, Gian Luca Grazi, Gian Ludovico Rapaccini, Andrea Ruzzenente, Filomena Morisco, Rodolfo Sacco, Riccardo Memeo, Michele Crespi, Adelmo Antonucci, Davide P. Bernasconi, Fabrizio Romano, Guido Griseri, Luca Aldrighetti, Guido Torzilli, Franco Trevisani. Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma. Annals of Surgery 2022; 275(4): 743 doi: 10.1097/SLA.0000000000005373
|
| 19 |
D. Lian, W. Wang, L. Liu, J. Wang, S. Rao, J. Zhou. CT volumetry helps predict prognosis of large hepatocellular carcinoma after resection. Clinical Radiology 2022; 77(8): e599 doi: 10.1016/j.crad.2022.03.018
|
| 20 |
Ahmed Shehta, Ahmed Farouk, Ahmed Nabieh Elghawalby, Mohamed Elshobary, Ahmed Aboelenin, Amgad Fouad, Mahmoud Abdelwahab Ali. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion. Journal of Surgical Research 2021; 266: 269 doi: 10.1016/j.jss.2021.04.011
|
| 21 |
Daisuke Yasui, Satoru Murata, Tatsuo Ueda, Fumie Sugihara, Shiro Onozawa, Chiaki Kawamoto, Shinichiro Kumita. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study. Acta Radiologica 2018; 59(3): 266 doi: 10.1177/0284185117717762
|
| 22 |
Byungje Bae, Sung Kyu Song, Eunyoung Choi, Chul-Woon Chung, Yongkeun Park. Secondarily estimated cure fraction and five-year recurrence-free conditional survival probabilities among patients undergoing surgical resection for hepatocellular carcinoma presenting with minor gross vascular invasion. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02331-1
|
| 23 |
Yue Zhang, Yi-Fan Wu, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Tao Wang, Fu-Quan Liu. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World Journal of Gastrointestinal Oncology 2019; 11(4): 310-321 doi: 10.4251/wjgo.v11.i4.310
|
| 24 |
G.K. Glantzounis, A. Paliouras, M.-C. Stylianidi, H. Milionis, P. Tzimas, D. Roukos, G. Pentheroudakis, E. Felekouras. The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review. European Journal of Surgical Oncology 2018; 44(2): 195 doi: 10.1016/j.ejso.2017.11.022
|
| 25 |
Zhenli Li, Mingda Zhao, Xingshun Qi, Yufu Tang, Shuqun Cheng. Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2023; 27(15): 2103 doi: 10.1111/jcmm.17808
|
| 26 |
Haohao Lu, Chuansheng Zheng, Bin Liang, Xiangwen Xia, Hongjie Fan. Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1280837
|
| 27 |
Takashi Kokudo, Kiyoshi Hasegawa, Yutaka Matsuyama, Tadatoshi Takayama, Namiki Izumi, Masumi Kadoya, Masatoshi Kudo, Yonson Ku, Michiie Sakamoto, Osamu Nakashima, Shuichi Kaneko, Norihiro Kokudo. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. Journal of Hepatology 2016; 65(5): 938 doi: 10.1016/j.jhep.2016.05.044
|
| 28 |
Shu-You Peng, Xu-An Wang, Cong-Yun Huang, Jiang-Tao Li, De-Fei Hong, Yi-Fang Wang, Bin Xu. Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus. World Journal of Gastroenterology 2018; 24(40): 4527-4535 doi: 10.3748/wjg.v24.i40.4527
|
| 29 |
Long-Hai Feng, Hui Dong, Wan-Yee Lau, Hua Yu, Yu-Yao Zhu, Yun Zhao, Yu-Xi Lin, Jia Chen, Meng-Chao Wu, Wen-Ming Cong. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2017; 143(2): 293 doi: 10.1007/s00432-016-2286-1
|
| 30 |
Kezhong Tang, Bo Zhang, Linping Dong, Lantian Wang, Yecheng Jin, Zhe Tang. Successful treatment of a huge hepatic carcinoma with right portal vein thrombosis. Medicine 2020; 99(17): e19636 doi: 10.1097/MD.0000000000019636
|
| 31 |
Sang-Hoon Kim, Deok-Bog Moon, Yo-Han Park, Sung-Gyu Lee, Ki-Hun Kim, Shin Hwang, Chul-Soo Ahn, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Minjae Kim, Byeong-Gon Na, Geunhyeok Yang, Sung Min Kim, Rak-kyun Oh. Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy. Annals of Surgical Oncology 2023; 30(7): 4279 doi: 10.1245/s10434-023-13316-7
|
| 32 |
Li-Hua Jiang, Ying-Li Hao, Jing-Wei Zhu. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 282 doi: 10.1016/j.clinre.2018.09.011
|
| 33 |
Brian I. Carr, Vito Guerra. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis. Digestive Diseases and Sciences 2016; 61(3): 937 doi: 10.1007/s10620-015-3922-3
|
| 34 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|